InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.17
(
0.65%
)
Bitcoin
91,876.65
(
2.24%
)
Post# of 183255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Buyfor1sell for2

Send PM Follow Ignore
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Buyfor1sell for2

Re: None

Tuesday, 05/19/2020 8:09:00 AM

Tuesday, May 19, 2020 8:09:00 AM

Post# of 183255
KTOV *Kitov Pharma Expects to Initiate Phase 1/2 Trial of NT-219 as Monotherapy Treatment of Advanced Solid Tumors, in Combination With Cetuximab for Treatment of Recurrent or Metastatic Solid Tumors and Head and Neck Cancer
https://finance.yahoo.com/news/kitov-present-preclinical-data-nt219-120510991.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up